Hangzhou, CHINA, June 10, 2025 (GLOBE NEWSWIRE) — Webus International Limited (“Webus” or the “Company”) (NASDAQ: WETO), a leading provider of AI-driven mobility solutions specializing in premium, customizable chauffeur services worldwide, today announced that its wholly-owned U.S. subsidiary, Wetour Travel Tech LLC, has executed a definitive three-year cooperation agreement with Utour LLC, one of the largest resource aggregators for Antelope Canyon and Horseshoe Bend tours in Las Vegas. The partnership secures Utour’s exclusive Upper & Lower Antelope Canyon allotments and combines them with WETO’s global digital reach, enabling faster, deeper access to critical U.S. tourism assets and offering premium multilingual experiences to travelers worldwide. Key Highlights •             Direct access to scarce assets – Guaranteed...

American Rebel Holdings, Inc.American Rebel Light Concert FeaturingAmerican Rebel (NASDAQ: AREB) CEO Andy Ross to Headline Patriotic Concert at Fort Campbell | American Rebel Light “Tall Boys” to be Served at the Army 250th Birthday Celebration Nashville, TN, June 10, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB), through its American Rebel Beverages subsidiary and America’s Patriotic Beer, American Rebel Light Beer (www.americanrebelbeer.com) proudly announces that it is hosting the Week of the Eagles Concert as part of the 101st Airborne Division’s Week of the Eagles Celebration, marking the 250th birthday of the United States Army on June 14, 2025. As America’s Patriotic Beer, American Rebel Light Beer will be served at all concession stands, and the Company’s CEO and Patriotic-rock...

RISHON LE ZION, Israel, June 10, 2025 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), an integrator of supply chain technologies for the aerospace, defense, industrial and retail sectors, announced today that it will release financial results for the second quarter of 2025 before the market opens on Thursday, August 21, 2025. BOS will host a video conference call on August 21, 2025 at 8:30 a.m. EDT. A question-and-answer session will follow management’s presentation. To access the video conference meeting, please click on the following link: https://us06web.zoom.us/j/89556415958?pwd=xKCYjpZC4qc0QbhuTFkZD5jaRzBDOs.1 For those unable to participate in the video conference, a recording of the meeting will be available the next day on the BOS website: boscom.com  About...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES Toronto, Ontario and Nucla, Colorado, June 10, 2025 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) (“Western” or the ”Company”) is pleased to announce that it plans to enter into an agreement with A.G.P. Canada Investments ULC (“A.G.P. Canada“) to act as sole underwriter and bookrunner for the Company in connection with a bought deal private placement financing of 5,882,374 units (each, a “Unit”) at a price of CAD $0.85 per Unit for aggregate gross proceeds of approximately CAD $5,000,000(the “Offering”).  Each Unit to be placed in the Offering is expected to be comprised of one common share and one common share purchase warrant, with each warrant being exercisable into one common share of the...

NORCROSS, Ga., June 10, 2025 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today announced that it will host a virtual key opinion leader (KOL) event on Monday, June 16, 2025 at 12:00 PM ET. To register, click here. The event will focus on the unmet need and current treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis and portal hypertension. Featured KOLs will include:Naga P. Chalasani, MD, Professor of Gastroenterology and Hepatology, Adjunct Professor of Anatomy, Cell Biology and Physiology, & Director of Terance Kahn Liver Research Program, Indiana University School of Medicine; and Naim Alkhouri, MD, FAASLD, DABOM, Chief Academic Officer, Summit Clinical...

RANCHO CUCAMONGA, Calif., June 10, 2025 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven eCommerce service provider and online retailer, today announced a strategic partnership with Borg Rise U.S., a dynamic and fast-growing player in digital content and social media commerce. This partnership marks a key milestone in iPower’s strategy to expand its omnichannel presence through influencer-driven and content-based sales models across platforms like TikTok, Instagram, and YouTube. Borg Rise U.S., with its strong network of content creators, livestreaming infrastructure, and experience in cross-border digital commerce, will collaborate with iPower to build and scale innovative social commerce campaigns. These campaigns will bridge content and conversion, enabling...

New System Features Include Extended Flight Time, Higher Payload Capacity, Enhanced Stability, Advanced Radar, and Improved Cleaning Durability FT. LAUDERDALE, FL, June 10, 2025 (GLOBE NEWSWIRE) — Duke Robotics Corp. (OTCQB: DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today announced the launch of its next-generation Insulator Cleaning Drone System (ICDS2), representing a significant technological advancement in the Company’s innovative utility maintenance drone solution. The ICDS2 builds upon the Company’s proven IC Drone technology with substantial performance improvements designed to enhance operational capabilities for utility providers worldwide.The ICDS2 features several key technological advancements over its predecessor:Extended...

On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 30 May 2025 30,500 578.18 17,634,501    Monday, 2 June 2025 1,800 574.61 1,034,298    Tuesday, 3 June 2025 1,800 575.82 1,036,476    Wednesday, 4 June 2025 1,800 581.26 1,046,268    Thursday, 5 June 2025 – – –    Friday,...

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One Dr. Vasconcelles to drive pipeline creation and execution BRISBANE, Calif., June 10, 2025 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Michael Vasconcelles, M.D., has joined the Company as Head of Research & Development (R&D). “We are thrilled to welcome Mike during this pivotal time at Day One. As an accomplished biopharmaceutical executive with more than 25 years of experience in building businesses and leading teams in oncology therapeutic...

ORLANDO, Fla., June 10, 2025 (GLOBE NEWSWIRE) — Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today provided the following response to last week’s false and misleading short attack. Our shareholders have been subjected to a false and uninformed short attack. The short seller’s report published on June 4, 2025 makes two key allegations: first, that Abacus relies too heavily on a single life expectancy provider (Lapetus Solutions), and second, that this reliance has significantly inflated our balance sheet valuation. Both are incorrect. Abacus remains resolute in our process, valuation methodology, and the benefit we provide to both policyholders and investors. Our market coverage analysts share this sentiment as well, and have supported our...